您现在的位置: 首页   -  产品中心   -  免疫学   -   抗体
α/β-Synuclein Recombinant Rabbit mAb (S-309-72)

α/β-Synuclein Recombinant Rabbit mAb (S-309-72)

货号: S0B0306
价格: 600
规格: 25μl
介绍: -
其他: -
产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    α/β-Synuclein
  • 分子别名

    Non-A beta component of AD amyloid, Non-A4 component of amyloid precursor (NACP), SNCA, PARK1, SNCB
  • 免疫原

    Synthetic Peptide
  • 细胞定位

    Secreted, Cytoplasm, Nucleus
  • Accession

    P37840, Q16143
  • 克隆号

    S-309-72
  • 抗体类型

    Recombinant mAb
  • 应用

    IHC-P, WB, IP
  • 反应种属 ?

    Hu, Ms, Rt
  • 预测反应种属
    (反应种属缩写表)

    Av, Bv, Pr, Mq, Pg, Or
  • 纯化方式

    Protein A
  • 浓度

    0.25 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05%BSA, 0.03% Proclin 300
  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

稀释度
应用 稀释度
WB 1:500
IP 1:25
IHC 1:1000-1:2000
背景介绍
  • Synucleins are a family of soluble proteins common to vertebrates, primarily expressed in neural tissue and in certain tumors. The synuclein family includes three known proteins: alpha-synuclein, beta-synuclein, and gamma-synuclein. Interest in the synuclein family began when alpha-synuclein was found to be mutated in several families with autosomal dominant Parkinson's disease. All synucleins have in common a highly conserved alpha-helical lipid-binding motif with similarity to the class-A2 lipid-binding domains of the exchangeable apolipoproteins. Normal cellular functions have not been determined for any of the synuclein proteins. Some data suggest a role in the regulation of membrane stability and/or turnover. Mutations in alpha-synuclein are associated with early-onset familial Parkinson's disease and the protein aggregates abnormally in Parkinson's disease, Lewy body disease, and other neurodegenerative diseases. Beta-synuclein is suggested to be an inhibitor of alpha-synuclein aggregation, which occurs in neurodegenerative diseases such as Parkinson's disease. Thus, beta-synuclein may protect the central nervous system from the neurotoxic effects of alpha-synuclein and provide a novel treatment of neurodegenerative disorders.

  • 免疫印迹

    • WB result of α/β-Synuclein Rabbit mAb
      Primary antibody: α/β-Synuclein Rabbit mAb at 1/500 dilution
      Lane 1: mouse brain lysate 20 µg
      Secondary antibody: Goat Anti-Rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 14 kDa
      Observed MW: 18 kDa

    • WB result of α/β-Synuclein Rabbit mAb
      Primary antibody: α/β-Synuclein Rabbit mAb at 1/500 dilution
      Lane 1: rat brain lysate 20 µg
      Secondary antibody: Goat Anti-Rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 14 kDa
      Observed MW: 18 kDa

  • 免疫沉淀

    • α/β-Synuclein Rabbit mAb at 1/25 dilution (1 µg) immunoprecipitating α/β-Synuclein in 0.4 mg mouse brain lysate.
      Western blot was performed on the immunoprecipitate using α/β-Synuclein Rabbit mAb at 1/500 dilution.
      Secondary antibody (HRP) for IP was used at 1/400 dilution.
      Lane 1: mouse brain lysate 20 µg (Input)
      Lane 2: α/β-Synuclein Rabbit mAb IP in mouse brain lysate
      Lane 3: Rabbit monoclonal IgG IP in mouse brain lysate
      Predicted MW: 14 kDa
      Observed MW: 18 kDa

  • 免疫组化

    • IHC shows positive staining in paraffin-embedded human cerebral cortex. Anti-α/β-Synuclein antibody was used at 1/1000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • Negative control: IHC shows negative staining in paraffin-embedded human colon. Anti-α/β-Synuclein antibody was used at 1/1000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • Negative control: IHC shows negative staining in paraffin-embedded human liver. Anti-α/β-Synuclein antibody was used at 1/1000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • Negative control: IHC shows negative staining in paraffin-embedded human tonsil. Anti-α/β-Synuclein antibody was used at 1/1000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • Negative control: IHC shows negative staining in paraffin-embedded human cervical squamous cell carcinoma. Anti-α/β-Synuclein antibody was used at 1/1000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • Negative control: IHC shows negative staining in paraffin-embedded human endometrial carcinoma. Anti-α/β-Synuclein antibody was used at 1/1000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded mouse cerebral cortex. Anti-α/β-Synuclein antibody was used at 1/1000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded rat cerebral cortex. Anti-α/β-Synuclein antibody was used at 1/1000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.